An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis

Clinical trial NCT06613490 · RECRUITING

Trial details

NCT number: NCT06613490
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Antisynthetase Syndrome Rheumatoid Arthritis

Start date: 2025-05-20
Primary completion: 2025-10-20
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.